About Us

Background

ACTM's Scientific Director, Dr. Greg Korbutt was a member of the original Edmonton Protocol team that developed a successful islet cell transplant protocol to treat Type 1 diabetes. Building upon this early success, Dr. Korbutt received 26.2 million dollars in funding from the Canada Foundation for Innovation, Alberta Enterprise and Advanced Education and the University of Alberta to build a state-of-art GMP cleanroom facility to support cell-based therapy manufacturing for all diseases and conditions that may be targeted by these innovative treatments. With construction complete in 2014, ACTM became the only facility of its kind in Western Canada and offers its services to researchers and industry worldwide.

Location

The GMP facility is located on the 7th and 8th floor of the Li Ka Shing Centre for Health Research Innovation in Edmonton, Alberta, Canada . campus map. Centered within the University of Alberta's Faculty of Medicine and located next to the University of Alberta Hospital, ACTM is well situated to interact with these research-intensive institutions in order to support manufacture and preparation of clinical and approved therapies. Our close proximity to the Edmonton International Airport enables efficient deliveries to and from our facility.

Our Mission

To help bring high quality and innovative therapies to patients in need by providing flexible solutions for these unique products combined with expert advice, value and support throughout the product lifecycle.

Our Values

Quality Focused: Quality is central to everything we do, no matter how big or small the project. We are committed to delivering superior quality products and service.

Integrity: We are honest, transparent and dedicated to helping our clients reach their goal of delivering safe and effective therapies to patients.

Client Driven: We strive to work collaboratively with our clients with open communication and shared goals to bring innovative cell-based therapies to patients.